Insufficient scRNA-seq data for expression of LCT at single-cell level.
Insufficient scRNA-seq data for expression of LCT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 88% | 6.59 | 211 / 241 | 0% | 0 | 0 / 0 |
lung | 67% | 3.44 | 387 / 578 | 9% | 0.40 | 109 / 1155 |
breast | 65% | 8.34 | 299 / 459 | 9% | 0.36 | 101 / 1118 |
brain | 71% | 4.98 | 1873 / 2642 | 0% | 0.00 | 1 / 705 |
intestine | 65% | 172.47 | 626 / 966 | 2% | 0.12 | 13 / 527 |
prostate | 63% | 2.85 | 155 / 245 | 0% | 0.02 | 2 / 502 |
thymus | 53% | 2.15 | 346 / 653 | 10% | 0.40 | 59 / 605 |
skin | 63% | 4.61 | 1134 / 1809 | 0% | 0 | 0 / 472 |
ovary | 61% | 2.46 | 109 / 180 | 0% | 0.00 | 1 / 430 |
kidney | 60% | 4.00 | 53 / 89 | 0% | 0.01 | 2 / 901 |
uterus | 58% | 2.42 | 98 / 170 | 1% | 0.01 | 3 / 459 |
peripheral blood | 55% | 10.48 | 514 / 929 | 0% | 0 | 0 / 0 |
adipose | 55% | 2.43 | 658 / 1204 | 0% | 0 | 0 / 0 |
muscle | 55% | 2.31 | 438 / 803 | 0% | 0 | 0 / 0 |
bladder | 52% | 2.52 | 11 / 21 | 1% | 0.06 | 7 / 504 |
stomach | 48% | 1.93 | 171 / 359 | 5% | 0.42 | 15 / 286 |
blood vessel | 50% | 1.95 | 666 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 43% | 5.20 | 624 / 1445 | 7% | 0.48 | 12 / 183 |
pancreas | 43% | 1.51 | 140 / 328 | 7% | 0.52 | 12 / 178 |
liver | 49% | 1.94 | 110 / 226 | 1% | 0.01 | 3 / 406 |
adrenal gland | 45% | 1.52 | 117 / 258 | 0% | 0 | 0 / 230 |
heart | 30% | 0.95 | 258 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.43 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901733 | Biological process | quercetin catabolic process |
GO_0046477 | Biological process | glycosylceramide catabolic process |
GO_2000892 | Biological process | cellobiose catabolic process |
GO_0005990 | Biological process | lactose catabolic process |
GO_0098591 | Cellular component | external side of apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0004336 | Molecular function | galactosylceramidase activity |
GO_0000016 | Molecular function | lactase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0140749 | Molecular function | phlorizin hydrolase activity |
GO_0008422 | Molecular function | beta-glucosidase activity |
GO_0080079 | Molecular function | cellobiose glucosidase activity |
GO_0017042 | Molecular function | glycosylceramidase activity |
GO_0004348 | Molecular function | glucosylceramidase activity |
Gene name | LCT |
Protein name | Lactase-phlorizin hydrolase-1 Lactase/phlorizin hydrolase (Lactase/glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Glycosylceramidase (EC 3.2.1.62) (Phlorizin hydrolase)] LCT Lactase |
Synonyms | LPH |
Description | FUNCTION: Broad specificity glycosidase of the intestinal brush border membrane that hydrolyzes lactose, the main sugar in mammalian milk, to produce D-glucose and D-galactose . The mature protein is composed of two domains that catalyze the hydrolysis of beta-glucopyranosides and beta-galactopyranosides, with a preference for hydrophilic aglycones (in lactose and cellobiose) for one domain and hydrophobic aglycones (in phlorizin and glycosylceramides) for the other . . |
Accessions | Q6Y1I9 H0Y4E4 Q45V77 P09848 ENST00000264162.7 ENST00000452974.1 |